COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 482: Articles 4811-4820  | Next

Safety and Effectiveness of SA58 Nasal Spray against COVID-19 Infection in Medical Personnel：An Open-label, Blank-controlled Study
Si, S., Jin, C., Cao, Y. R., Li, J., Kan, B., Xue, F., Xie, X. S., Fang, L., Zeng, G., Zhang, S., Hu, Y., Dong, X.
10.1101/2022.12.27.22283698 — Posted: 2022-12-31
COVID-19 in Cambodia: Epidemiology, Response, and Lessons Learned, 27 January 2020 to 30 June 2022
Chhim, S., Ku, G. M., Mao, S., Put, W. v. d., Van Damme, W., Ir, P., Chhea, C., Or, V.
10.1101/2022.12.24.22283920 — Posted: 2022-12-31
On temporal changes in the role of different age groups in propagating the Omicron epidemic waves in England
Goldstein, E.
10.1101/2022.12.30.22283949 — Posted: 2022-12-31
A Statistical Analysis on COVID-19 Pandemic in the City of Toronto
Kaazempur-Mofrad, A.
10.1101/2022.12.28.22284001 — Posted: 2022-12-30
Effectiveness of Sotrovimab in Preventing COVID-19-related Hospitalizations or Deaths Among U.S. Veterans
Young-Xu, Y., Korves, C., Zwain, G., Satram, S., Drysdale, M., Reyes, C., Cheng, M. M., Epstein, L., Marconi, V. C., Ginde, A.
10.1101/2022.12.30.22284063 — Posted: 2022-12-30
Outcomes After Percutaneous Tracheostomy in Patients with COVID-19: A Single-Center Series of 377 Cases
Alshukry, A., Alhindi, A., Alzuabi, M., Husain, S., Tarakmeh, M., Alqattan, S., Al Bader, A., Alhabib, A., Bu Abbas, M.
10.1101/2022.12.28.22283971 — Posted: 2022-12-30
Surveillance for SARS-CoV-2 in Ohio's wildlife, companion, and agricultural animals
Ehrlich, M., Madden, C., McBride, D., Nolting, J. M., Huey, D., Kenney, S., Wang, Q., Saif, L., Vlasova, A., Dennis, P., Lombardi, D., Gibson, S., McLaine, A., Lauterbach, S., Yaxley, P., Winston, J., Diaz-Campos, D., Pesapane, R., Flint, M., Flint, J., Junge, R., Faith, S. A., Bowman, A. S., Hale, V. L.
10.1101/2022.12.30.522311 — Posted: 2022-12-30
Automated assessment of chest CT severity scores in patients suspected of COVID-19 infection
Ajmera, P., Rathi, S., Dosi, U., Kalli, S. L., Luthra, A., Khaladkar, S., Pant, R., Seth, J., Mishra, P., Gawali, M., Pargaonkar, Y., Kulkarni, V., Kharat, A.
10.1101/2022.12.28.22284027 — Posted: 2022-12-30
Study of an age-based Covid-19 outbreak model and the effect of demo-graphic structure of a state on infectious disease dynamics
Basak, A., Sanyal, T.
10.1101/2022.12.28.22284021 — Posted: 2022-12-30
Bridging the gap_Estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel
Harries, M., Jaeger, V., Rodiah, I., Hassenstein, M. J., Kurosinski, M. A., Ortmann, J., Dulovic, A., Gornyk, D., Schneiderhan-Marra, N., Kuczewski, C., Schlotz, M., Dreier, M., von Holt, I., Brinkmann, M., Hovardovska, O., Strengert, M., Krause, G., Sester, M., Klein, F., Petersmann, A., Karch, A., Lange, B.
10.1101/2022.12.30.22284061 — Posted: 2022-12-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).